Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
amisulpride, Quantity: 50 mg
Southern Cross Pharma Pty Ltd
Amisulpride
Tablet, uncoated
Excipient Ingredients: sodium starch glycollate type A; lactose monohydrate; microcrystalline cellulose; magnesium stearate; hypromellose
Oral
90, 30, 60
(S4) Prescription Only Medicine
Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
Visual Identification: White round flat tablets with diameter 7mm; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-01-29